Tammy, just a small clarification: Herceptin and Perjeta are not hormone-based immunotherapies. They’re for HER2-pos cancer and target the HER2 receptor, which is not a hormone receptor. If someone also has ER or PR positive receptors, then you’d get other meds such as AIs to block those.
For ER-negative, HER2-positive breast cancer, treatments often include targeted therapies like trastuzumab (Herceptin), pertuzumab (Perjeta), or ado-trastuzumab emtansine (Kadcyla). Chemotherapy is also commonly used, sometimes in combination with targeted therapies. Surgery and radiation may be part of the treatment plan Show Full Answer
I was posting the info for Esta who has ER- HER2+, and you’re absolutely right.
Esta wants to get info from women having her diagnosis.
Happy Valentine’s Day🥰